




The generation of oxidative stress-induced rearrangements in Saccharomyces cerevisiae mtDNA is dependent on the Nuc1 (EndoG/ExoG) nuclease and is enhanced by inactivation of the MRX complex


Piotr Dzierzbickia1, Aneta Kaniak-Golika1*, Ewa Malc2, Piotr Mieczkowski2 and Zygmunt Ciesla1*













Abbreviations: BER, base excision repair; MMR, mismatch repair; mtDNA, mitochondrial DNA; ROS, reactive oxygen species; 8-oxoG, 8-oxo-7,8-dihydroguanine; HR, homologous recombination. 








Running title: Oxidative lesion-induced rearrangements of mtDNA


Key words: mitochondrial genome; oxidative lesions; mtDNA rearrangements; MRX; Nuc1


*Corresponding authors: Aneta Kaniak-Golik and Zygmunt Ciesla, 


































Since mitochondrial DNA (mtDNA) is located close to the respiratory chain, a major source of reactive oxygen species (ROS), the mitochondrial genome is constantly exposed to oxidative damage. The efficient repair of oxidative lesions in mtDNA plays a central role in maintaining the stability of the mitochondrial genome [1-3]. If not repaired, lesions in mtDNA may result in mutations, which in humans may cause a variety of hereditary diseases such as mitochondrial encephalomyopathies and neuropathies, and are associated with the pathogenesis of a variety of complex disorders including heart disease, neurodegenerative diseases such as Parkinson’s, Alzheimer’s and Huntington’s, and other neurological disorders [4]. Oxidative damage to mitochondria and accumulation of somatic mutations in mtDNA also appear to be a feature of both normal aging process and cancer [3-5].
The yeast Saccharomyces cerevisiae proved to be a very useful model system to study mechanisms responsible for maintaining the stability of mtDNA. Though cells of this yeast species can survive without respiration and mtDNA is dispensable for their viability in laboratory conditions, it has been shown that loss of mtDNA in the budding yeast leads to nuclear genome instability through a defect of essential iron-sulfur cluster biogenesis that is dependent on normal mitochondrial function [6]. In addition, normal mitochondrial function is required for survival of yeast cells in late-stationary cultures [7] or during chronological aging [8,9]. Thus, it is not surprising that mtDNA stability is maintained by several, partially overlapping, DNA repair pathways in yeast cells [10-13]. One of the pathways, the mitochondrial base excision repair (mtBER) is relatively well characterized. An important enzyme functioning in mtBER is the Ogg1 glycosylase that excises 8-oxoG, an abundant oxidative lesion in DNA, opposite cytosine [14]. Another DNA glycosylase acting in the mitochondria is the Ntg1 protein. This broad specificity enzyme excises several oxidized pyrimidines and purines [15,16]. Several lines of evidence suggest that, besides mtBER, other pathways may also participate in the repair of oxidative lesions in mtDNA. These pathways include in S. cerevisiae: the mitochondrial repair system whose functioning depends on the activity of the Msh1 protein, a homologue of the bacterial mismatch protein, MutS [13,17-19] and, in addition, a repair pathway/s based on mechanisms of homologous recombination [11,13].
Oxidative damage of mtDNA may lead to two major types of changes within mitochondrial genome of S. cerevisiae. These two kinds of alterations within mtDNA are manifested either by appearance of respiration-deficient petite rho¯ mutants often having large deletions and other rearrangements of the mitochondrial genome [20], or by induction of mitochondrial point mutations. The frequency of spontaneous petite mutants is very high, usually 1-2% in wild-type strains, and may be significantly enhanced under oxidative stress conditions [21]. On the other hand, the frequency of spontaneous and induced mitochondrial point mutations is several orders of magnitude lower than the incidence of petite mutants [10,13,22,23]. This dramatic difference clearly indicates that the mechanisms underlying the generation of these two kinds of alterations in mtDNA are divergent. It has previously been suggested that formation of petite rho¯ mutants may be related to mitochondrial recombination processes [20]. In contrast, the generation of mitochondrial point mutations is most likely due to replication errors [10]. 
The question arises which factors determine that primary oxidative lesions in mtDNA are converted either to mitochondrial point mutations or to rearrangements of the mitochondrial genome. As reactive oxygen species (ROS) produced in mitochondria can lead to over 100 different types of modifications in DNA [24], one obvious determinant is the nature of the modification present in mtDNA. For example, 8-oxoG, an abundant form of oxidized base, is highly mutagenic, because it mispairs with adenine during DNA replication, thereby leading to GC→T:A transversions [14]. On the other hand, the presence of replication blocking-lesions, such as FapyG [25], may result in the formation of single-strand breaks (SSBs) that could lead, in turn, to the generation of double-strand breaks (DSBs). In addition, adjacent SSBs generated by direct action of ROS on opposite DNA strands may be converted to DSBs [26]. Unrepaired DSBs may generate a serious threat to the integrity of the mitochondrial genome. 
To get further insight into mechanisms leading to the instability of mtDNA under oxidative stress conditions, we used antimycin A, a well known drug which induces this stress by direct blocking of electron transport during respiration in yeast mitochondria as well as in those from higher eukaryotes [27]. The results of this work indicate that treatment of yeast cells with antimycin leads exclusively to the generation of large-scale deletions in the mitochondrial genome. Interestingly, the generation of antimycin-induced deletions in mtDNA is dependent on the activity of the mitochondrial Nuc1 nuclease, the yeast ortholog of mitochondrial EndoG and ExoG nucleases in mammalian cells [28]. Furthermore, our data indicate that the MRX complex (reviewed in [29,30]) counteracts antimycin-induced instability of mtDNA and is also required for efficient allelic homologous recombination in mtDNA.

2. Materials and methods
2.1. Yeast strains and plasmids
Strains of S. cerevisiae used in this study are listed in Table 1. To introduce kanMX-marked deletions of RAD50, RAD27 and XRS2 into our strains, we used the following strategy. We amplified corresponding deletion cassettes by PCR using genomic DNA extracts from appropriate BY4341 deletion strains as templates and primers whose sequences corresponded to the gene-specific oligonucleotides A and D designed within the Saccharomyces Genome Deletion Project (available on http://www- sequence.stanford.edu/group/yeast_deletion_project/deletions3). The amplified cassettes were transformed into either the FF18733 strain or both parental strains used in the arg8mt test [13], MAT, YAK29/1, and MATa, CAB183-1 (for RAD50 and XRS2 deletions). Resulting transformant clones resistant to G418 were verified by PCR, following the strain verification criteria established within the Saccharomyces Genome Deletion Project. For these PCR verification tests, in addition to the above-mentioned primers A and D, the other gene-specific oligonucleotides, B and C (internal to the ORF to be deleted), and the kanMX marker-specific oligonucleotides, kanB and kanC, were used (the strain verification criteria and sequences of all the primers listed above are available online at the site of the Saccharomyces Genome Deletion Project as mentioned above). To isolate strains with deletion alleles marked with the hphMX marker (yku70::hphMX and nuc1::hphMX), conferring resistance to hygromycin B, we replaced kanMX-marked deletion alleles in appropriate BY4741 deletion strains with the hphMX4 marker using the system described in [31]. Using genomic DNA extracts from the resulting yku70::hphMX or nuc1::hphMX strains, we amplified the hphMX-marked deletion cassettes by PCR with corresponding oligonucleotides A and D as above. An analogous approach was used to extract the ogg1::TRP1 deletion cassette from the strain CD138. To introduce these deletion alleles into our strains, we used the PCR products to construct appropriate single and double deletion heterozygous strains (derived from a wild-type homozygous diploid strain obtained by crossing two isogenic wild-type strains, FF18733 and FF18734; Table 1). Hygromycin-resistant clones were isolated and tested for the presence of the appropriate deletion allele by PCR (with the oligonucleotides: D for the cognate gene and hphC [5’ TTGGGCGCAGGGTCGATGCG] for hphMX). The ogg1::TRP1 deletion allele was tracked after transformations by PCR with the primers A and D for OGG1 (the reference for the primers as above; the OGG1 A-D PCR product on the template of the wild-type chromosomal copy of OGG1 is shorter than the corresponding product obtained from the ogg1::TRP1 deletion chromosome template). Finally, MATa haploid deletion strains were isolated by dissection of tetrads issued in sporulation of PCR-verified heterozygous strains.
To obtain a CTA1-overexpressor plasmid to be used in tests with antimycin-treated cells in the YPG medium, we replaced the URA3 marker in the pAH521 (Yep352-CTA1) plasmid [32], generously provided by M. Skoneczny, with the ura3::kanMX3 swap-marker cassette from the plasmid M3927 [33], a kind gift from D. Stillman. The same marker replacement was performed with the YEp352 vector [34]. 
 
2.2. Growth media and growth conditions
	YP medium contained 1% yeast extract, 1% Bacto-peptone and 2% dextrose (YPD) or 2% glycerol (YPG). YNBD medium contained 0.67% yeast nitrogen base and 2% dextrose. Solid media contained 2% Bacto agar. Non-respiring petite colonies were scored on YPG medium supplemented with 0.1% glucose (YPGD). Oligomycin-resistant mutants (Olir) and erythromycin-resistant mutants were scored on YPG medium, buffered at pH 6.2, containing either 3 g/ml oligomycin or 4 mg/ml erythromycin, respectively. 

2.3 mtDNA sequencing
Total cellular DNA was isolated from the wild-type strain and 26 antimycin-induced petite mutants. Sequencing libraries were prepared using Illumina TruSeqTM DNA Sample Prep Kit (TruSeq DNA). Briefly, 5 ml of yeast cultures were grown on YPD, pelleted and kept at -20oC overnight which increased mtDNA recovery. Total cellular DNA was extracted and sheared to sizes between 200 and 800 bp by using Covaris S2 sonicator according to the Illumina TruSeq DNA protocol. Libraries were prepared using TruSeq DNA kit with bar-coded adapters for multiplexing. Libraries were size selected for fragments around 300 base pairs using Pippin Prep automatic DNA size selection system (Sage Science). Libraries were analyzed and quantified using a LabChip GX automated electrophoresis system (Caliper). DNA was diluted to 15 nM and samples were pooled together at batches of 10, loaded on the flow cell, and sequenced on a HiSeq2000 sequencer (Illumina). We performed paired-end sequencing (2 × 100 cycles), using chemistry version 3. These libraries were run with the Illumina pipeline v 1.8. Illumina reads were mapped to a reference genome at greater than 100 x average coverage and were analyzed using CLC Bio Genomics Workbench 4.9 (CLC Bio GW). 

2.4. Determination of mutant frequencies after treatment with antimycin A or menadione 
To measure the frequency of petite formation, single colonies from YPG plates were inoculated into 4 ml YPG and grown to OD600 0.4-0.6 at 30ºC. Menadione or antimycin A were then added to a final concentration of 10 mM or 0.5 μg/ml, respectively, and incubated for 2 or 4 h. Cells were then harvested by centrifugation, washed with water, resuspended in fresh YPG and incubated for further 4 h at 30ºC. Appropriate dilutions were then plated on YPGD plates and the percentage of petites was scored after growth for 3 days at 30ºC. Colonies were scored as rho+ or rho¯/ rho0 by the tetrazolium overlay method [35]. The mean value from each set of at least 10 cultures was used to determine the percentage of petite colonies. To measure the frequency of oligomycin-resistant (Olir) mutants, and erythromycin-resistant (Eryr) mutants, cultures were grown and treated with menadione and antimycin as described above. After the final 4 hr incubation in YPG without a drug (see above), cells were harvested by centrifugation, washed with water and plated either on YPG + oligomycin or YPG + erythromycin. Appropriate dilutions of the cultures were also spread on YPGD plates to calculate the number of petite and grande cells in tested cultures. The mean value derived from at least 10 independent cultures was used to determine the frequency of mutants resistant to oligomycin (calculated per number of grande cells). P values for statistical significance of any differences in mutant frequencies between pairs of strains were determined by applying the nonparametric Mann-Whitney criterion using the program STATISTICA (Statsoft), unless stated otherwise. In some experiments with antimycin-treatment, the post-treatment incubation of cells in drug-free YPG was extended to 16 hours, as indicated. 

2.5. Assay of mtDNA recombination
To asses levels of mitochondrial recombination within the ARG8m gene, parental wild-type cells or cells deleted for the RAD50 or XRS2 gene carrying either the cox3::arg8mt:: polyAT(+1) or cox3::arg8m- 1 allele were crossed. The resulting diploids were selected and the frequency of arginine prototrophs scored as described previously with some modifications [13]. Briefly, 40 l of a fresh overnight YPD preculture (approx. 2.5 x 106 cells) of each wild-type parent or 60 l of a deletion mutant parental culture in YPD (for cultures of YAK29/1 and its derivative strains, adenine was supplemented in the medium at 55 mg/l), were mixed in a tube, spun down and resuspended in 1 ml of fresh YPD. Cells were pelleted and incubated in the pellet for 1 hour at 30ºC. Afterwards, the mating mixture was briefly vortexed and incubated for 2 hours at 27ºC with shaking. An aliquot of 50 l from the resulting mating culture was added to 5 ml of YNBD medium supplemented with arginine (40 mg/l) and leucine (220 mg/l). After 3 days of incubation at 27ºC with shaking, appropriate dilutions of diploid cultures (to facilitate resuspension of cells, EDTA was added at concentration of 20 mM to the cultures before preparation of dilutions in sterile distilled water) were plated on YNBD with arginine and leucine to establish the titre of all selected diploid cells and on the same medium without arginine to determine the frequency of Arg+ cells. Raw values of Arg+ frequencies in diploid cultures were normalized to estimated retention of mtDNA in diploid cells based on frequencies of mitochondrial mit- rho+ genome retention established for each parental strain (by a test cross with an appropriate tester strain: GW22 for YAK29/1 and its derivative strains, and MCC259 for CAB183-1 and CAB183-1-derived strains), as described in [13]. 

2.6. Determination of ROS levels
The dichlorofluorescein diacetate (DCFH-DA) assay was performed on whole-cell extracts according to the procedure described by Doudican et al. [22]. Briefly, this assay utilizes the oxidant-sensitive probe DCFH-DA to assess intracellular ROS levels. Cultures were grown at 30ºC in YPG medium to OD600 0.4–0.6. Cells were washed twice with distilled water, resuspended in 10 ml distilled water, and divided into 1.5 ml aliquots. Next, DCFH-DA was added to a final concentration of 10 μM. Cells were incubated in dark at 30ºC for 30 min. Afterwards, each sample was washed twice and resuspended in 1.5 ml of a solution containing 1% sodium dodecyl sulfate, 2% Triton X-100, 100 mM NaCl, 10 mM Tris–HCl pH 8, 1 mM EDTA. After addition of 0.3 ml acid-washed glass beads, cells were vortexed for 10 min. Samples were incubated at room temperature for 10 min and then pelleted. Fluorescence of 200 μl of the supernatant was measured using Cary Eclipse fluorescence spectrophotometer and Cary Eclipse Scan Application 1.1 program, with a fluorescence excitation of 485 nm and emission at 520 nm.
	The dihydroethidine (DHE) assay was performed similarly as DCFH-DA assay (the final concentration of DHE in the assay also at 10 M) except that fluorescence was measured with a fluorescence excitation at 518 nm and emission at 605 nm.

2.7. Determination of ATP levels
ATP levels in cells from tested cultures were determined with the use of “ATP Determination Kit” form Invitrogen/Molecular Probes according to the experimental protocol proposed in the manufacturer’s instructions. In this assay, the luciferase enzyme oxidizes D-luciferin with a concomitant emission of light (maximum at 560 nm) at the expense of ATP that is added to reactions with cell extracts. Within some range of ATP concentrations, the intensity of light emitted is proportional to the concentration of ATP in the reaction. Cell extracts, providing ATP in these reactions, were prepared according to the TCA-diluted method from the Thermo Labsystems Application Note 200 “The extraction of ATP from biological material” (and references therein). The application note is available online as a pdf file at www.pathtech.com.au/files/.../ExtractionATP.pdf (​http:​/​​/​www.pathtech.com.au​/​files​/​...​/​ExtractionATP.pdf​). Briefly, aliquots of 50 l were retrieved from tested cultures (about 106 cells/sample) and snap-frozen in liquid nitrogen. Immediately after de-freezing a sample on ice, 50 l of the extraction buffer (10% TCA [trichloroacetic acid], 4 mM EDTA) were added to cells and samples were incubated for 5 minutes on ice. Afterwards, TCA in extracted samples was neutralized by addition of 5 ml 0.1 M Tris-acetate, 2 mM EDTA (pH 7.75). After extraction, samples were usually kept frozen at -80ºC until they were used for the ATP assay. For these assays, 10 l-aliquots of cell extracts were mixed with 90 l of the luciferase-luciferin standard reaction solution prepared according to the ATP assay kit instruction. After 15 minutes of incubation at room temperature, luminescence generated in the reactions was measured with a Glomax 20/20 luminometer rented from the Promega distributor “Symbios Sp. z o.o.” (Straszyn, Poland). 

3. Results
3.1. Antimycin increases ROS level and decreases ATP level
	In order to get better insight into mechanisms by which oxidative stress leads to the instability of the mitochondrial genome, to induce this stress we used antimycin A. Antimycin A has been shown to block electron transport during respiration in isolated mitochondria from yeast as well as from higher eukaryotes [27]. It interferes with electron transfer through the complex III in a manner that leads to the accumulation of reduced forms of ubiquinone (ubiquinol and ubisemiquinone) upstream of the blocked complex. Ubisemiquinone reacts with molecular oxygen to produce superoxide. For comparison, we tested also the stability of mtDNA in menadione-treated cells. In contrast to antimycin, menadione does not block directly the activity of the electron transport chain, but acts as a typical redox-cycling drug, which is able to accept electrons from electron carriers and to donate them to oxygen to form superoxide [36,37].
	First, prior to the investigation of the effect of antimycin- and menadione-induced oxidative stress on the stability of the mitochondrial genome, we estimated, under conditions used in this study, the levels of ROS in cells treated with either of these drugs. To do this, cells grown in YPG medium were treated for 4 h either with antimycin or menadione and cellular ROS levels were determined using two different fluorescent probes. Generation of superoxide was assessed with dihydroethidine (DHE) [38] and generation of hydrogen peroxide with 2’7’-dichlorofluorescein diacetate (DCFH-DA), which is hydrolyzed by intracellular esterases to non-fluorescent DCFH, which, in turn, is oxidized to dichlorofluorescein (DCF) [39]. Table 2 shows that cells treated for 4 h either with antimycin or menadione displayed a similar increase in the level of superoxide as compared to untreated cells (by 1.5-fold and 1.7-fold, respectively). However, cells exposed to antimycin exhibited a much stronger elevation in the level of hydrogen peroxide than cells treated with menadione (5.2-fold and 2.5-fold increase, respectively).
	Next, we wished to know to what extent the treatment with antimycin or menadione, leads to a bioenergetic deficit in cells exposed to these drugs. To test this, we determined ATP level in antimycin- or menadione-treated cells grown on glycerol, a non-fermentable carbon source. Table 3 shows that cells exposed for 4 h to antimycin displayed approximately 50% decrease in the ATP level as compared to that in untreated cells, the result consistent with previous data showing that antimycin dramatically reduces ATP production in isolated mitochondria [40]. On the other hand, the treatment with menadione resulted in a reduction of ATP by only 20%. This result shows that antimycin treatment affects ATP levels more severely than menadione and leads to a severe cellular energy crisis. 

3.2. Antimycin induces the generation of respiration deficient petite mutants 
Three parallel assays were used to estimate the level of mitochondrial mutagenesis in cells treated either with antimycin or menadione. In the first assay, we estimated the level of respiration-deficient petite mutants, a method routinely used to measure mitochondrial mutagenesis in yeast [13,21,22]. In two other assays, the frequency of mutants resistant to oligomycin (Olir) and mutants resistant to erythromycin (Eryr) was determined and used as a measurement of mtDNA point mutagenesis. Resistance to oligomycin is acquired through specific point mutations in the mitochondrial OLI1 and OLI2 genes, encoding subunits 9 and 6, respectively, of the mitochondrial ATPase complex [41,42]. Therefore, acquisition of oligomycin resistance can be used, as reported previously [13,18], as a convenient assay of mtDNA mutagenesis. Resistance to erythromycin is acquired through specific mutations in the mitochondrial 21S rRNA gene and acquisition of resistance to this drug is a standard method of measuring mtDNA point mutagenesis [43]. The incidence of respiration-deficient petite mutants and the frequency of Olir and Eryr mutants were determined in antimycin- and menadione-treated cells grown on glycerol in YPG medium. Figure 1A shows that, antimycin-treated cells displayed approximately an increase of 10-fold in the incidence of petite mutants as compared to that in untreated cells. On the other hand, antimycin was completely ineffective in the generation of Olir and Eryr point mutants. Interestingly, a completely reverse result was obtained with menadione-treated cells grown in YPG medium. Cells exposed to menadione displayed a marked increase in the frequency of Olir mutants as compared to untreated cells. However, in contrast to antimycin-treated cells, the exposure to menadione failed to result in enhanced generation of respiration-deficient petite mutants. Importantly, the induction of respiration-deficient petite mutants by antimycin was dependent on the carbon source used in the growth medium. Figure 1B shows that in contrast to cells growing in YPG medium, antimycin-treatment of cells grown on glucose in YPD medium, under conditions when most of cellular ATP is supplied by glycolysis and not by mitochondrial respiration, failed to increase the level of petite mutants. It was previously reported that antimycin causes no loss of ATP in cells growing on glucose [40]. It should be noted (Table 2), that antimycin-treatment, irrespectively whether cells were grown on glucose or glycerol, resulted in a similar increase in the level of hydrogen peroxide (4.2-fold and 5.2-fold, respectively). This strongly suggests that antimycin-induced generation of petite mutants is not exclusively related to the ROS level, but is associated also with a concomitant shortage of cellular ATP. 
	The different effect of menadione and antimycin on the stability of mtDNA was also observed when the frequency of the Olir and respiration deficient petite mutants was determined in cells deleted for the OGG1 gene, encoding the Ogg1 glycosylase, an important enzyme functioning in mtBER. The glycosylase excises 8-oxoG, an abundant oxidative lesion in DNA, and is also known to cleave the DNA replication-blocking lesion FapyG [14,44]. We found that in the ogg1Δ deletion mutant menadione dramatically enhances the incidence of Olir mutants, but is completely ineffective in inducing petite mutants. In contrast, although the level of spontaneous Olir mutants in the ogg1Δ strain was elevated several-fold compared to that in the wild-type strain, the result consistent with previous data [13,18], it was not further enhanced by antimycin treatment (supplementary Fig. S1). It should be emphasized that very similar effects of antimycin and menadione on the stability of mtDNA were observed in experiments using strains with different genetic backgrounds than that of FF18733, e.g. with BY4742 (data not shown). We conclude therefore, that the treatment of yeast cells with antimycin results preferentially in the formation of respiration-deficient petite mutants, but hardly induces the generation of mitochondrial point mutations. In contrast, menadione is an effective inducer of mitochondrial point mutations. 
Supplementary material related to this article found, in the online version, at http://dx.doi.org/10.1016/j.mrfmmm.2012.12.004.

3.3. The production of antimycin-induced petite mutants is triggered by an increased level of hydrogen peroxide 
One likely explanation of the diverse effects of menadione and antimycin on the stability of mtDNA is that the treatment with menadione increases preferentially the level of oxidative lesions giving rise to mitochondrial base-substitution mutations, such as 8-oxoG, but fails to induce lesions leading to the generation of respiration-deficient petite mutants. In this context, it is worth emphasizing that the exposure of yeast cells to menadione does not lead to double-strand breaks (DSBs) [45]. In contrast, DSBs are induced in hydrogen peroxide-treated yeast cells. We hypothesized that the approximate 5-fold increase in the level of hydrogen peroxide in antimycin-treated cells (Table 2) could be responsible for the induction of petite mutants. To verify this hypothesis, we examined antimycin-induced generation of respiration-deficient petite mutants in cells harboring a multicopy plasmid bearing the CTA1 gene that encodes catalase A, a well-known scavenger of H2O2. Catalase A is localized both to peroxisomes and mitochondria and a significant import of catalase A into mitochondria occurs when cells are grown under respiratory conditions [46]. As shown in Figure 2, the frequency of antimycin-induced petites was markedly reduced in cells harboring the pCTA1 plasmid as compared to that in cells carrying the vector plasmid. This result indicates that it is hydrogen peroxide which is mainly responsible for the generation of petite mutants in cells exposed to antimycin. 

3.4. Analysis of antimycin-induced rearrangements in mtDNA
The appearance of respiration-deficient petite mutants is often due to large deletions and other rearrangements of the mitochondrial genome [20]. To get preliminary insight into the structure of mitochondrial genomes in antimycin-induced petite mutants, mtDNA from independently isolated petite clones was subjected to a restriction analysis. This analysis revealed that mtDNA isolated from antimycin-induced petites showed gross changes in the restriction profiles as compared to mtDNA derived from respiration-proficient cells, suggesting that exposure to antimycin leads to gross rearrangements in the structure of mtDNA that result in the rho¯ phenotype (data not shown). To analyze mitochondrial genomes from antimycin-induced petite mutants more closely, we subjected their mtDNA to whole genome sequencing. Total cellular DNA of 26 independent antimycin-induced petite mutants and the isogenic wild-type strain with functional mtDNA was sequenced and analyzed. The reads were mapped to the S288c reference genome v.3 [47,48] with at least 100x coverage of the chromosomes. The difference in average coverage fold between mitochondrial and nuclear DNA was used for calculating the copy number of mtDNA. This value was then used to calculate the coverage for a single mtDNA repeat. 
A comparison of the wild-type and petite mtDNA coverage revealed that the wild-type mtDNA is almost uniformly covered by the sequencing reads. In the mtDNA from the petite strains, fragments of the genome that are deleted or amplified can be recognized by a significantly lower or higher coverage, respectively, of that relevant part of the reference genome. In antimycin-induced petite mutants, we observed large fragments of mtDNA with no or almost no (<1% of average coverage) reads mapping to the reference and the remaining fragments with extremely high number of mapped reads. Out of the 26 petites analyzed, 3 were lacking mtDNA (rho0). The rest were rho¯ mutants containing large deletions ranging from half to almost all of the mitochondrial genome. The rho¯ mutants retain different segments of mtDNA that are mostly continuous (rarely in a few discrete fragments – strains 7c, 9a) and mostly made up from intragenic regions (Fig. 3). All, except one (1a – not shown), include a region containing at least one ori-sequence in the amplified fragment. The ori sequences have been proposed as origins of replication of mtDNA as their sequence is similar to those found in origins of mtDNA replication from vertebrates [49,50]. Each ori sequence contains three conserved GC-rich clusters: A, B and C and a transcription promoter upstream from cluster C. Eight ori sequences have been found in S. cerevisiae mtDNA, but only four of those are considered active as only ori1, -2, -3 and -5 contain functional RNA polymerase sites [51-53]. Among the antimycin-induced rho¯ mutants, we observed three distinct groups with the amplified region containing either ori2 (Fig. 3B), or ori3 (Fig. 3C), or a region between ori5 and ori1 including one or both of these ori sequences, and in one case also ori2 (Fig. 3D). Some rho¯ mutants contain just an ori sequence, but others include larger stretches of mtDNA. In most cases those fragments are near an ori site without rearrangements (only two contained discontinuous fragments, as mentioned above). We also see some of the mutants having an ori site overrepresented, which indicates further amplifications and the loss of non-ori mtDNA. Altogether, these results indicate that antimycin preferentially induces the ori-dependent rho¯ formation. 

3.5. The frequency of antimycin-induced respiration-deficient mutants is enhanced in the rad50 and xrs2 strains 
Single-strand breaks (SSBs) are believed to be a very common kind of DNA damage introduced directly by interaction of ROS with the sugar-phosphate backbone of DNA [54]. Unrepaired ROS-induced SSBs may, in turn, be converted into significantly more genotoxic double-strand breaks (DSBs). In addition, DSBs can be introduced directly into DNA due to oxidative attack [54]. Furthermore, SSBs and consequently DSBs may be formed when DNA polymerase encounters a DNA replication-blocking lesion such as FapyG [25]. Since it has been previously shown that the exposure of the yeast cells to hydrogen peroxide results in the production of DSBs [45], we hypothesized that hydrogen peroxide-induced DSBs may be a primary cause of large-scale mtDNA deletions in antimycin-treated cells. If this assumption is correct, one should expect that yeast strains deficient in the DSB repair should be more susceptible to antimycin-induced rearrangements in the mitochondrial genome than strains proficient in this process.
There are two main pathways involved in DSB repair, homologous recombination (HR) and non-homologous end-joining (NHEJ) [55-57]. In S. cerevisiae, both pathways require the Mre11–Rad50–Xrs2 (MRX) complex, which is rapidly recruited to DSBs [29,30]. In addition, NHEJ requires Ku70/80, a heterodimer encoded by the YKU70 and YKU80 genes in S. cerevisiae [58,59].
It was previously reported that both Mre11 and Rad50 were localized also in the mitochondrial compartment [60,61], although their possible role in metabolism of mtDNA was not immediately recognized after these first reports. However, it has recently been shown that loss of MRX and Ku70/80 complexes significantly affects the rate of spontaneous direct repeat mediated deletions (DRMD) in mtDNA [62]. We reasoned that, if either HR or NHEJ plays an important role in the prevention of oxidative lesion-induced rearrangements of mtDNA, one would expect that antimycin-induced generation of respiration-deficient petite mutants could be significantly affected by the loss of the MRX complex or/and of the Yku70/80 complex. To test this possibility, the rad50Δ, xrs2Δ, yku70Δ single mutants, as well as the yku70Δ rad50Δ double mutant strain, were treated with antimycin and the frequency of respiration-deficient petite mutants compared to that of the wild–type strain. Figure 4A shows that the frequency of antimycin-induced respiration-deficient petite mutants was approximately 2-fold higher in the rad50Δ and xrs2Δ mutants than that in the wild-type control strain. In contrast, the incidence of antimycin-induced petites in yku70Δ was at the level observed in the wild-type control strain (Fig. 4B). In addition, although the frequency of spontaneous respiration-deficient mutants in the rad50Δ yku70Δ double mutants was elevated as compared to the single mutants, the result consistent with a current report [62], the frequency of antimycin-induced respiration deficient petite mutants in the yku70Δ rad50Δ double mutant was not significantly different from that in the rad50Δ single mutant. This result suggests that the Ku70/80 complex, and consequently NHEJ, does not play a significant role in the prevention of antimycin-induced rearrangements of mtDNA. 
Next, we asked whether a higher susceptibility of the rad50Δ and xrs2Δ mutants to mtDNA rearrangements provoked by antimycin could be due to the deficiency in mitochondrial HR. To test this possibility, we used an assay developed in this laboratory and designed to estimate the frequency of mitochondrial allelic recombination events within the ARG8m reporter gene [13]. Using this test, we compared the level of mitochondrial recombination in crosses between the rad50Δ and xrs2Δ deletion strains with that of the isogenic wild-type control crosses. Fig. 4D shows that the incidence of recombination events within ARG8m in crosses between rad50Δ or xrs2 strains is decreased by about 40% as compared to control crosses. This result suggests that the enhanced frequency of antimycin-induced rearrangements in mtDNA in mutants with inactive MRX complex may be, at least partially, due to the deficiency in homologous allelic recombination.  
	To investigate further the mechanism by which the MRX complex is involved in maintaining the stability of mtDNA, we studied the generation of antimycin-induced petite mutants in an rad50Δ ogg1Δ double deletion mutant, which lacks both the activity of the MRX complex and the activity of the Ogg1 glycosylase, an important enzyme functioning in mtBER [14]. Figure 5 shows that the frequency of antimycin-induced petite mutants in the ogg1Δ single mutant was not significantly different from that observed in the wild-type strain. Remarkably, the enhanced generation of antimycin-induced petite mutants observed in the rad50Δ strain was further increased by simultaneous deletion of OGG1. We conclude, therefore, that concurrent inactivations of the MRX complex and the Ogg1 glycosylase render cells exceptionally susceptible to antimycin-induced rearrangements of mtDNA The synergistic interaction between the rad50Δ and ogg1Δ deletions suggests that the MRX complex and the Ogg1 glycosylase are involved in overlapping pathways which are responsible for the repair of antimycin-induced oxidative lesions triggering rearrangements of the mitochondrial genome. 

3.6. The generation of antimycin-induced rearrangements in mtDNA is dependent on the activity of the Nuc1 nuclease 
Sequence analysis of mtDNA isolated from antimycin-induced respiration-deficient petite mutants revealed that their phenotype is due to large-scale deletions in the mitochondrial genome and often only small fragments of the wild-type mtDNA sequence are preserved (Fig. 3). We hypothesized that the formation of these large deletions in the mitochondrial genome of antimycin-treated cells, observed under conditions of enhanced ROS production and a concomitant shortage of intramitochondrial energy, may be mediated by a nuclease(s) known to be localized in the mitochondrial compartment. To verify this assumption, we investigated whether the absence of either the Rad27 or Nuc1 nuclease, previously reported to be involved in mtDNA metabolism, may modify the antimycin effect on the stability of mtDNA. Rad27, the S. cerevisiae ortholog of mammalian FEN1, is involved in many DNA transactions including cleavage of 5’ DNA flaps created during Okazaki fragment processing, processing of intermediates during nuclear long-patch BER, prevention of sequence duplications and repeat sequence expansions, as well as in DSB repair [63-66]. It has been reported that Rad27 (FEN1) functions in mitochondria of both yeast and mammalian cells [67,68]. S. cerevisiae rad27Δ mutants display an increased rate of Eryr point mutants, but, in contrast, exhibit a decrease in mitochondrial direct-repeat mediated deletions (DRMD) [69]. The mechanisms underlying these mitochondrial phenotypes of rad27Δ are not understood. The Nuc1 nuclease is the yeast ortholog of mammalian EndoG, which is located in mitochondria, yet translocates into the nucleus of apoptotic cells [70]. Nuc1p exhibits both endo- and exonuclease activities with the polarity of the exonuclease activity 5’→3’ [71]. Besides its role in the yeast apoptosis, it was previously reported that Nuc1 is involved in mitochondrial recombination in yeast cells [72]. Figure 6A shows that the exposure of rad27Δ cells to antimycin resulted in about the same induction of respiration-deficient petite mutants as in the wild-type cells. In contrast, this induction was markedly reduced in antimycin-treated nuc1Δ cells. We determined also the frequency of antimycin-induced respiration-deficient petite strains in a nuc1Δ rad50Δ double mutant. This experiment (Fig. 6B) was performed under somewhat different conditions than that shown in Figure 6A, i.e. after 4 hr long exposure to antimycin the cells were incubated in antimycin-free YPG medium not for 4 h, as in the experiment presented in Figure 6A, but for the additional 12 hours. Under these experimental conditions the incidence of antimycin-induced petites in the wild-type strain was evidently higher than in cells incubated after treatment for 4 h in the drug-free medium. It appeared that both the nuc1Δ single mutant and the nuc1Δ rad50Δ double mutant displayed a significant decrease in the frequency of induced petites. However, a significant fraction of respiration-deficient mutants was still induced by antimycin in the absence of the Nuc1 nuclease. These results demonstrate that the Nuc1 nuclease plays an important role in the formation of antimycin-induced large-scale mtDNA deletions, but, in addition to Nuc1, yet another unidentified mitochondrial nuclease(s) is also involved in the generation of large-scale deletions in mtDNA.

4. Discussion	 
Several new findings emerged from this work. First, we show that the treatment of yeast cells growing on non-fermentable carbon source with antimycin results in preferential generation of respiration-deficient petite mutants having gross alterations in the structure of mtDNA. Second, we show that inactivation of RAD50 or XRS2, two genes encoding components of the MRX complex, leads to enhanced frequency of antimycin-induced rearrangements in the mitochondrial genome and this phenotype correlates with the reduction of mitochondrial homologous recombination in these mutants. Third, the generation of antimycin-induced large deletions in mtDNA is dependent on the activity of the Nuc1 nuclease. 
The treatment of cells growing on a non-fermentable carbon source with antimycin frequently induces rho¯ mutants having large deletions in mtDNA. In contrast, the exposure of cells to menadione does not lead to enhanced generation of rho¯ mutants, but efficiently increases the level of mitochondrial point mutations. The question arises what is the mechanism(s) underlying the diverse effects of antimycin and menadione on the stability of mtDNA. One possible explanation is based on our observation that cells exposed to antimycin exhibit a much stronger elevation in the level of hydrogen peroxide than cells treated with menadione. Our finding that high-copy overexpression of the CTA1 gene coding for catalase A suppresses the enhanced generation of rho¯ mutants in antimycin-treated cells clearly points out to H2O2 accumulating in mitochondria as a ROS molecule that is responsible for antimycin-induced rearrangements in mtDNA. As a matter of fact, since antimycin by blocking the respiratory chain induces ROS production specifically in the mitochondrial compartment, while menadione, a redox-cycling compound, operates in the whole cell (since both mitochondrial and cytosolic proteins were detected as targets of oxidation damage upon menadione treatment [73]), the difference in H2O2 level within mitochondrial matrix between antimycin- versus menadione-treated cells may be actually much bigger than that shown in Table 2. It is reasonable to assume that the nature of the primary oxidative lesions within mtDNA, and, consequently, the nature of the final alterations in the structure of mtDNA produced by either menadione or antimycin may be related to the actual level of H2O2 within mitochondrial matrix. A very high level of intramitochondrial H2O2 in antimycin-treated cells may result in the preferential generation of lesions, such as SSBs or DSBs, which eventually lead to rearrangements in the mitochondrial genome. Moreover, the exposure of cells grown on glycerol-containing medium to antimycin results in about 50% decrease in cellular ATP level versus only a slight ATP reduction in menadione-exposed cells (Table 3). Furthermore, it should be noticed that although antimycin-treated cells grown on glucose-containing medium, under conditions when cellular energy is derived from glycolysis, display a similar increase in the level of hydrogen peroxide as cells grown on glycerol-containing medium (Table 2), this is not accompanied by an increased frequency of mtDNA deletions. Thus, the increase in the level of hydrogen peroxide and the shortage of intramitochondrial energy are required concomitantly to induce rearrangements in mtDNA. Interestingly, the situation when enhanced ROS production is accompanied by a simultaneous drop in ATP within mitochondria is often observed in mammalian cells bearing certain pathogenic mitochondrial mutations [4]. Classic examples of such mutations are mitochondrial DNA mutations in the ATP6 gene, e.g. at nt8993, resulting in neurological phenotypes of variable severity in humans [74]. It would be interesting to examine how these mutations affect the stability of mtDNA.
It should be emphasized that our results are consistent with a previous observation by Subik et al. [75], who have shown that the treatment of S. cerevisiae cells growing on a glucose-containing medium both with antimycin and bongkrekic acid, which inhibits import of glycolytically-produced ATP from the cytosol into mitochondria, results in a continuous and random loss of mitochondrial genes. Conversely, the treatment of cells growing in a glucose-containing medium solely with antimycin failed to have a significant effect on mtDNA. While this work was in progress, Gomes et al. [76] reported an interesting precedent of a mutant deleted for COQ10, a gene required for coenzyme Q transport in mitochondria. Due to the redox imbalance in coq10cells, this mutant displays an increased production of H2O2 accompanied by a high instability of mtDNA [77]. In the most recent report [76], the authors have shown, by an extensive series of genetic manipulations, a remarkable correlation between the level of H2O2 in coq10cells and a loss of the wild-type mtDNA.
We report in this study that rad50Δ and xrs2Δ mutants deficient in the activity of the MRX complex, which is critical for detection of DSBs and initiation of their repair by either HR or NHEJ, display an enhanced frequency of antimycin-induced rearrangements in mtDNA (Fig. 4). We demonstrate also that the incidence of antimycin-induced respiration-deficient mutants is similar in the yku70Δ single mutant to that of the wild-type control. In addition, antimycin-treated cells of the rad50Δ yku70Δ double mutant display a similar frequency of petites as the rad50Δ single mutant. These results indicate that mitochondrial NHEJ does not play a significant role in the prevention of oxidative lesion-induced rearrangements in mtDNA. Our findings imply also that the increased susceptibility of MRX-deficient mutants to antimycin-induced rearrangements in mtDNA may be due to their decreased potential for sustaining mitochondrial allelic HR. In accordance with this assumption, we have found that the incidence of recombination events within ARG8m in crosses between rad50Δ or between xrs2Δ strains is significantly decreased as compared to control crosses. For this reason, we propose that the generation of mtDNA rearrangements initiated by oxidative lesions in mtDNA of antimycin-treated cells is counteracted by MRX-dependent allelic homologous recombination. Accordingly, our data strongly support previous suggestions that recombination does play an important role in the repair of oxidative lesions in the yeast mitochondrial genome. It has been shown that an S. cerevisiae mhr1-1 mutant, which is partially defective in mitochondrial recombination at 30ºC, the temperature permissive for growth of the strain on respiratory carbon sources, accumulates at non-permissive temperature more oxidative lesions in mtDNA than the wild-type strain, suggesting that recombination processes may be involved in the repair [11]. Biochemical studies on the isolated Mhr1 protein revealed that it catalyzes homologous pairing essential for homologous DNA recombination [78]. Furthermore, a synergistic effect on the generation of respiration-deficient petite mutants has been observed in strains deleted for both NTG1 and PIF1, both in normal conditions and under oxidative stress [22,79]. PIF1 encodes a DNA helicase implicated in mtDNA recombination [80], though its exact mitochondrial function in the regulation of mtDNA stability awaits further inquiry. In addition, the yeast mitochondrial nucleoid protein Mgm101, which is related to the Rad52-type recombination proteins, was currently shown to be required for mitochondrial repeat-mediated recombination [81]. A defect in the Mgm101 function decreases tolerance to oxidative damage, and induces mtDNA fragmentation in vivo.
It is justifiable to presume that the role of the MRX complex in the mitochondrial compartment may be similar to that the same complex plays in the nucleus. It was previously shown that the MRX complex, besides its essential role in Spo11-mediated meiotic recombination [82,83], is also required for DSB repair in cells in the vegetative growth state [29]. For example, mre11 mutant cells exhibit decreased frequencies of ionizing radiation-induced interhomolog recombination [84]. Moreover, it has been reported that heteroallelic recombination between homologous chromosomes is not induced in rad50Δ cells upon exposure to methyl methansulfonate [85]. By analogy, we postulate that the MRX complex plays an important role in the recombinational repair of oxidative lesion-induced DSBs in mtDNA and acts to prevent rearrangements of the mitochondrial genome under oxidative stress conditions. 
However, alternative mechanisms by which the MRX complex may be also involved in the prevention of antimycin-induced rearrangements in mtDNA should be considered. The MRX complex is required for checkpoint responses to DSBs [86,87]. Inactivation of the MRX complex may result in the failure of the Mec1/Rad53 kinase cascade to increase dNTP levels after cells are challenged by DNA-damaging agents [88]. It was previously proposed that processed DSBs trigger MRX-dependent checkpoint activation by oxidative DNA damage [89]. Thus, rad50Δ and xrs2Δ mutants may be unable to increase dNTP levels after cells are exposed to antimycin. In consequence, the efficiency of both mtDNA replication and mtDNA repair may be more severely affected than in MRX-proficient strains. It was previously reported that lower dNTP levels increase the frequency of mitochondrial DNA-deficient petite cells while higher dNTP levels result in reduced petite formation [90-92]. On the other hand, it was recently reported that the MRX complex is involved in BER and may be required for efficient polymerase activity in this repair pathway [93]. This raises the possibility that MRX complex deficiency may affect also the functioning of mitochondrial BER.
A significant finding which emerged from this work indicates that the Nuc1 nuclease, the yeast ortholog of the mammalian EndoG and ExoG nucleases [28,70] plays an important role in the generation of large-scale deletions in antimycin-treated cells. The involvement of Nuc1 in programmed cell death in yeast cells has been described [70]. However, the role of Nuc1 in mtDNA metabolism is so far not understood. Gene inactivation studies in yeast have suggested earlier that Nuc1 is involved in mitochondrial DNA recombination. Zassenhaus and collaborators speculated that the enzyme produced recombinogenic DNA ends by introducing single-stranded gaps into double-stranded DNA using its 5’→3’-exonuclease activity [72]. The present work uncovers an important role of Nuc1 in mtDNA metabolism. We demonstrate in this study that the generation of antimycin-induced rearrangements in mtDNA is markedly reduced in strains deleted for the NUC1 gene. This observation suggests that the fate of, at least, some types of oxidative lesions in mtDNA, e.g. SSBs and DSBs, is dependent on the activity of the enzyme. It is worth noting that ExoG, a mammalian ortholog of Nuc1, has recently been reported to be required for repairing endogenous SSBs in the mitochondrial genome [94]. We propose the 5’→3’-exonuclease activity of Nuc1 is involved in processing of mtDSB ends. Under conditions of acute oxidative stress accompanied by a shortage of intramitochondrial energy, e.g. in cells treated with antimycin, the Nuc1 activity leads to extensive degradation of mtDNA. This Nuc1-mediated processing is likely to be the first step which eventually results in the formation of rho¯ mutants whose mtDNA are deleted for most of the mitochondrial genome. The subgenomic mtDNA molecules in these petites arise presumably by means of non-allelic recombination. However, it should be noticed that in the absence of the Nuc1 nuclease a significant fraction of respiration-deficient mutants is still induced by antimycin. This observation suggests that, in parallel to Nuc1, another, yet unidentified, mitochondrial nuclease(s) is involved in the generation of large-scale deletions in mtDNA. 
Our observation that the generation of antimycin-induced large-scale deletions in mtDNA is dependent on Nuc1 raises the intriguing possibility that under conditions of oxidative stress Nuc1 may be involved in the selective degradation of damaged copies of mtDNA. It was previously postulated that mitochondria are capable of abandoning damaged mtDNA, owing to multiple copies of mtDNA [95]. In addition, it has already been reported that degradation processes operate on oxidatively damaged mtDNA in mammalian cells [96]. Presumably, the degradation of oxidatively damaged mtDNA, together with mtDNA repair pathways such as mtBER, may represent a component of the complex machinery that is responsible for the protection of the mitochondrial genome integrity. 
In conclusion, the results presented in this work imply that the level of intramitochondrial energy plays a key role in directing the fate of oxidative lesions in mtDNA. Once the level of mitochondrial ATP and other nucleoside triphosphates drops below a certain threshold level, several kinds of oxidative lesions, such as DSBs, may be processed by the Nuc1 nuclease to produce large-scale deletions in mtDNA. In accordance with a current report [62], we show also that the MRX complex functions in the mitochondrial compartment and acts to maintain the mtDNA integrity possibly on a pathway of mitochondrial allelic homologous recombination. 
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Fig. 1. Mitochondrial DNA instability induced by antimycin or menadione. Cultures of FF18733 were grown either in YPG (A) or YPD medium (B). Cells were treated either with antimycin or menadione for 4 h, and then cultivated for further 4 h in fresh YPG or YPD, respectively. The frequencies of Olir, Eryr (except for cells treated with menadione in YPG medium) and petite mutants were determined. Each bar in panels A and B represents the average value obtained from two separate experiments in which at least 10 independent cultures of each strain was used. Error bars indicate standard deviations. 

Fig. 2. Effect of the pCTA1 plasmid on the generation of antimycin-induced petite mutants. Cultures of FF18733  either the pCTA1 plasmid or YEp352 (vector) were grown in YPG medium supplemented with G418 (200 μg/ml). Cells were treated for 4 h with antimycin, and subsequently grown for 16 h in fresh YPG. The frequency of petite mutants was then determined. Each bar represents the average value obtained from two separate experiments in which 10 independent cultures of each strain was used. Error bars indicate standard deviations. ***P< 0.0005.

Fig. 3. Sequence analysis of mtDNA in antimycin-induced respiration-deficient petite mutants. Two wild-type mtDNA strains and 22 antimycin-induced rho¯ mutants were analyzed. Sequences of mtDNA from rho¯ mutants were divided into 3 groups based on the ori site they include. (A) The analysis of wild-type mtDNA. (B) The plot corresponds to mtDNA from rho¯ mutants containing ori2. (C) The analysis of mtDNA from rho¯ mutants containing ori3. (D) The plot corresponds to mtDNA from rho¯ mutants containing ori5 and/or ori1 (in one case also ori2). The labels corresponding to the lines in panels B-D represent individual rho¯ strains that were used in sequencing.The labels corresponding to the lines in panels B-D represent individual rho¯ strains that were used in sequencing. In all four panels, the X axis shows the nucleotide position within mtDNA, whereas the Y axis shows the coverage per one copy of mtDNA. The positions of ori sequences are represented by red arrows on the x axis. The arrowheads show the orientations of ori sequences, i.e. the direction from cluster C to cluster A [53]. The map of the wild-type mtDNA, in the same scale as the plots, is included above the Panel A with positions of the main genes coded by mtDNA. 

Fig. 4. Effect of antimycin on the stability of mtDNA in rad50Δ and xrs2Δ mutants (A) and in yku70Δ and rad50Δ yku70Δ mutants (B). Mitochondrial recombination within the ARG8m gene (C and D). (A) Cultures of FF18733, YAK322 (rad50Δ) and YAK490 (xrs2Δ) grown in YPG medium were treated for 4 h with antimycin; subsequently, the cells were cultivated in fresh YPG medium for 4 h. The frequency of petite mutants was determined. Each bar represents the average value obtained from two separate experiments in which at least 10 independent cultures of each strain were tested. (B) Cultures of FF18733, YAK322 (rad50Δ), YAK671 (yku70Δ), and YAK675 (rad50Δ yku70Δ), were treated as in (A). Each bar represents the average value obtained from three separate experiments in which at least 10 independent cultures of each strain were tested. **P< 0.005, ***P< 0.0005. (C) Schematic representation of the two arg8m alleles in mtDNA of the parental strains. The interval between the mutational alterations, conferring Arg¯ phenotype, in the two alleles of the parental strains is indicated. (D) Crosses between YAK29/1 (cox3::arg8m-1) and CAB183-1 (cox3::arg8m:: (AT)16 +1), YAK55 (YAK29/1 rad50Δ) and YAK58 (CAB183-1 rad50Δ), YAK516 (YAK29/1 xrs2Δ) and YAK518 (CAB183-1 xrs2Δ), were performed as described in Section 2 and the percentage of Arg+ in diploid cultures determined. Each bar represents the average of median values obtained from at least three separate experiments in which 10 to 16 crosses for each parental pair, as listed above, were tested. The values were normalized as described in Section 2 and [13]. Error bars indicate standard deviations. *P< 0.05, **P< 0.005 (as determined by two-tailed t-test statistics).  

Fig. 5. Effect of antimycin on the stability of mtDNA in the ogg1Δ rad50Δ double mutant. Cultures of FF18733, CD138 (ogg1Δ), YAK322 (rad50Δ) and YAK870 (ogg1Δ rad50Δ) grown in YPG medium were treated with antimycin for 4 h and subsequently cultivated in antimycin-free YPG for 16 h. The frequency of petite mutants was determined. Each bar represents the average value obtained from three separate experiments in which 10 independent cultures of each strain were tested. Error bars indicate standard deviations. ***P< 0.0005. 

Fig. 6. Effect of antimycin on the stability of mtDNA in rad27Δ, nuc1Δ single mutants and a nuc1Δ rad50Δ double mutant. (A) Cultures of FF18733, YAK254 (rad27Δ) and YAK512 (nuc1Δ) grown in YPG medium were treated with antimycin for 4 h and subsequently cultivated in antimycin-free YPG medium for 4 h. The frequency of petite mutants was determined. Each bar represents the average value obtained from two separate experiments in which 10 independent cultures of each strain were tested. Error bars indicate standard deviations. (B) Cultures of FF18733, YAK512 (nuc1Δ), YAK322 (rad50Δ) and YAK757 (nuc1Δ rad50Δ) grown in YPG medium were treated with antimycin for 4 h and subsequently cultivated in antimycin-free YPG medium for 16 h. Each bar represents the average value obtained from two separate experiments in which 10 independent cultures of each strain were tested.  ***P< 0.0005.










FF18733	MATa leu2-3,112 trp1-289 ura3-52 his-7 lys1-1	F. Fabre
FF18734	MATα leu2-3,112 trp1-289 ura3-52 his-7 lys1-1	F. Fabre
CD138	FF18733 ogg1Δ::TRP1	S. Boiteux
CD183	FF18733 ntg1Δ::URA3	S. Boiteux
CAB183-1	MATa  ura3-52 leu2-3 lys2 his3 arg8Δ::hisG/cox3::arg8m (AT)16 + 1	E. A. Sia
YAK29/1	MATα ade2-101 leu2 ura3-52 arg8Δ::URA3 kar1-1/cox3::arg8m  - 1	[14]
GW22	MATa lys2/+ cox3-421	T. D. Fox








YAK512	(a segregant like FF18733) nuc1Δ::hphMX	This study
YAK671	(a segregant like FF18733) yku70Δ::hphMX	This study




















 untreated			35.76 ± 0.86	1
+ menadione			58.96 ± 4.94	1.7
+ antimycin  A			52.04 ± 3.77	1.5
	YPG	DCFH-DA		
 untreated			15.88 ± 1.79	1
 + menadione			38.91 ± 7.19	2.5
 + antimycin A			81.80 ± 17.12	5.2
	YPD	DCFH-DA		
 untreated			17.63 ± 2.32	1
 + antimycin A			73.37 ± 12.12	4.2









Cells	RLU/106 cells	Relative level (%)
untreated	1175 ± 102	100
+ antimycin A	647 ± 74	55.1
+ menadione	950 ± 107	80.1










For the assay, FF18733 was grown in YPG at 30ºC and treated in fresh YPG with indicated compounds for 4 hours (concentrations of these compounds during the treatment as in Section 2). Cells were harvested immediately after the treatment. The assay was performed as described in Section 2. The RLU values are in relative luminescence units measured with a Glomax 20/20 luminometer/Promega in its internal luminescence units. Luminescence of a blank sample (an aliquot of YPG without cells equal to the volume of a cell sample) was deducted from each measurement of a cell sample. Each value represents the mean value obtained from duplicate samples retrieved from five cultures treated in the same way. Standard deviations are indicated. For the difference between ATP level in cells treated with antimycin and that in untreated cells P value was 0.01 (using the Mann-Whitney statistics). 
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